Literature DB >> 21236661

Apoptosis and oncogenesis: give and take in the BCL-2 family.

Fabien Llambi1, Douglas R Green.   

Abstract

The mitochondrial pathway of apoptosis constitutes one of the main safeguards against tumorigenesis. The BCL-2 family includes the central players of this pathway that regulate cell fate through the control of mitochondrial outer membrane permeabilization (MOMP), and important progress has been made in understanding the dynamic interactions between pro-apoptotic and anti-apoptotic BCL-2 proteins. In particular, recent studies have delineated a stepwise model for the induction of MOMP. BCL-2 proteins are often dysregulated in cancer, leading to increased survival of abnormal cells; however, recent studies have paradoxically shown that apoptosis induction can under some circumstances drive tumor formation, perhaps by inducing compensatory proliferation under conditions of cellular stress. These observations underline the complexity of BCL-2 protein function in oncogenesis.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21236661      PMCID: PMC3040981          DOI: 10.1016/j.gde.2010.12.001

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  95 in total

1.  MTCH2/MIMP is a major facilitator of tBID recruitment to mitochondria.

Authors:  Yehudit Zaltsman; Liat Shachnai; Natalie Yivgi-Ohana; Michal Schwarz; Maria Maryanovich; Riekelt H Houtkooper; Frédéric Maxime Vaz; Francesco De Leonardis; Giuseppe Fiermonte; Ferdinando Palmieri; Bernhard Gillissen; Peter T Daniel; Erin Jimenez; Susan Walsh; Carla M Koehler; Soumya Sinha Roy; Ludivine Walter; György Hajnóczky; Atan Gross
Journal:  Nat Cell Biol       Date:  2010-05-02       Impact factor: 28.824

2.  Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia.

Authors:  Marina Konopleva; Rooha Contractor; Twee Tsao; Ismael Samudio; Peter P Ruvolo; Shinichi Kitada; Xingming Deng; Dayong Zhai; Yue-Xi Shi; Thomas Sneed; Monique Verhaegen; Maria Soengas; Vivian R Ruvolo; Teresa McQueen; Wendy D Schober; Julie C Watt; Tilahun Jiffar; Xiaoyang Ling; Frank C Marini; David Harris; Martin Dietrich; Zeev Estrov; James McCubrey; W Stratford May; John C Reed; Michael Andreeff
Journal:  Cancer Cell       Date:  2006-11       Impact factor: 31.743

3.  Influence of Bcl-2 family members on the cellular response of small-cell lung cancer cell lines to ABT-737.

Authors:  Stephen K Tahir; Xiufen Yang; Mark G Anderson; Susan E Morgan-Lappe; Aparna V Sarthy; Jun Chen; Robert B Warner; Shi-Chung Ng; Stephen W Fesik; Steve W Elmore; Saul H Rosenberg; Christin Tse
Journal:  Cancer Res       Date:  2007-02-01       Impact factor: 12.701

4.  p53-mediated hematopoietic stem and progenitor cell competition.

Authors:  Tanya Bondar; Ruslan Medzhitov
Journal:  Cell Stem Cell       Date:  2010-04-02       Impact factor: 24.633

5.  Exon skipping in Mcl-1 results in a bcl-2 homology domain 3 only gene product that promotes cell death.

Authors:  C D Bingle; R W Craig; B M Swales; V Singleton; P Zhou; M K Whyte
Journal:  J Biol Chem       Date:  2000-07-21       Impact factor: 5.157

6.  The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues.

Authors:  T Lindsten; A J Ross; A King; W X Zong; J C Rathmell; H A Shiels; E Ulrich; K G Waymire; P Mahar; K Frauwirth; Y Chen; M Wei; V M Eng; D M Adelman; M C Simon; A Ma; J A Golden; G Evan; S J Korsmeyer; G R MacGregor; C B Thompson
Journal:  Mol Cell       Date:  2000-12       Impact factor: 17.970

Review 7.  Cytoplasmic functions of the tumour suppressor p53.

Authors:  Douglas R Green; Guido Kroemer
Journal:  Nature       Date:  2009-04-30       Impact factor: 49.962

8.  MYC-induced myeloid leukemogenesis is accelerated by all six members of the antiapoptotic BCL family.

Authors:  L J Beverly; H E Varmus
Journal:  Oncogene       Date:  2009-01-12       Impact factor: 9.867

9.  Cdc6 stability is regulated by the Huwe1 ubiquitin ligase after DNA damage.

Authors:  Jonathan R Hall; Evelyn Kow; Kathleen R Nevis; Chiajung Karen Lu; K Scott Luce; Qing Zhong; Jeanette Gowen Cook
Journal:  Mol Biol Cell       Date:  2007-06-13       Impact factor: 4.138

10.  The HECT-domain ubiquitin ligase Huwe1 controls neural differentiation and proliferation by destabilizing the N-Myc oncoprotein.

Authors:  Xudong Zhao; Julian Ik-Tsen Heng; Daniele Guardavaccaro; Richeng Jiang; Michele Pagano; Francois Guillemot; Antonio Iavarone; Anna Lasorella
Journal:  Nat Cell Biol       Date:  2008-05-18       Impact factor: 28.824

View more
  106 in total

1.  Role of apoptosis-inducing factor, proline dehydrogenase, and NADPH oxidase in apoptosis and oxidative stress.

Authors:  Sathish Kumar Natarajan; Donald F Becker
Journal:  Cell Health Cytoskelet       Date:  2012-02-01

2.  ABT-263 induces G1/G0-phase arrest, apoptosis and autophagy in human esophageal cancer cells in vitro.

Authors:  Qing-Huan Lin; Fu-Chang Que; Chun-Ping Gu; De-Sheng Zhong; Dan Zhou; Yi Kong; Le Yu; Shu-Wen Liu
Journal:  Acta Pharmacol Sin       Date:  2017-07-10       Impact factor: 6.150

3.  Mutation-induced protein interaction kinetics changes affect apoptotic network dynamic properties and facilitate oncogenesis.

Authors:  Linjie Zhao; Tanlin Sun; Jianfeng Pei; Qi Ouyang
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-13       Impact factor: 11.205

4.  The Study of Apoptosis-inducing Effects of Three Pre-apoptotic Factors by Gallic Acid, Using Simulation Analysis and the Comet Assay Technique on the Prostatic Cancer Cell Line PC3.

Authors:  Javad Saffari-Chaleshtori; Ehsan Heidari-Sureshjani; Fahimeh Moradi; Hojjatollah Molavian Jazi; Esfandiar Heidarian
Journal:  Malays J Med Sci       Date:  2017-08-18

Review 5.  Deregulation of cell signaling in cancer.

Authors:  Filippo G Giancotti
Journal:  FEBS Lett       Date:  2014-02-20       Impact factor: 4.124

6.  Design, synthesis and evaluation of marinopyrrole derivatives as selective inhibitors of Mcl-1 binding to pro-apoptotic Bim and dual Mcl-1/Bcl-xL inhibitors.

Authors:  Chunwei Cheng; Maria E Balasis; Yan Liu; Thomas P Garner; Rongshi Li; Kenyon G Daniel; Jerry Li; Yong Qin; Evripidis Gavathiotis; Said M Sebti
Journal:  Eur J Med Chem       Date:  2014-11-20       Impact factor: 6.514

7.  The TP53 Apoptotic Network Is a Primary Mediator of Resistance to BCL2 Inhibition in AML Cells.

Authors:  Tamilla Nechiporuk; Stephen E Kurtz; Olga Nikolova; Tingting Liu; Courtney L Jones; Angelo D'Alessandro; Rachel Culp-Hill; Amanda d'Almeida; Sunil K Joshi; Mara Rosenberg; Cristina E Tognon; Alexey V Danilov; Brian J Druker; Bill H Chang; Shannon K McWeeney; Jeffrey W Tyner
Journal:  Cancer Discov       Date:  2019-05-02       Impact factor: 39.397

Review 8.  Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis.

Authors:  L Ouyang; Z Shi; S Zhao; F-T Wang; T-T Zhou; B Liu; J-K Bao
Journal:  Cell Prolif       Date:  2012-10-03       Impact factor: 6.831

Review 9.  Revisiting the hallmarks of cancer.

Authors:  Yousef Ahmed Fouad; Carmen Aanei
Journal:  Am J Cancer Res       Date:  2017-05-01       Impact factor: 6.166

10.  RRM2 regulates Bcl-2 in head and neck and lung cancers: a potential target for cancer therapy.

Authors:  Mohammad Aminur Rahman; A R M Ruhul Amin; Dongsheng Wang; Lydia Koenig; Sreenivas Nannapaneni; Zhengjia Chen; Zhibo Wang; Gabriel Sica; Xingming Deng; Zhuo Georgia Chen; Dong M Shin
Journal:  Clin Cancer Res       Date:  2013-05-29       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.